Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Free Report) EVP Jeremiah Rawlins Bickham sold 26,233 shares of the firm’s stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of $65.18, for a total transaction of $1,709,866.94. Following the sale, the executive vice president now owns 24,845 shares of the company’s stock, valued at $1,619,397.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Ryan Specialty Price Performance
NYSE RYAN opened at $64.49 on Friday. Ryan Specialty Holdings, Inc. has a 12-month low of $41.49 and a 12-month high of $69.03. The stock has a market capitalization of $16.86 billion, a PE ratio of 121.68, a price-to-earnings-growth ratio of 1.54 and a beta of 0.62. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.81. The company has a 50 day moving average price of $59.13 and a two-hundred day moving average price of $54.15.
Ryan Specialty (NYSE:RYAN – Get Free Report) last released its quarterly earnings results on Thursday, August 1st. The company reported $0.58 EPS for the quarter, beating analysts’ consensus estimates of $0.56 by $0.02. Ryan Specialty had a net margin of 10.21% and a return on equity of 48.08%. The company had revenue of $695.40 million for the quarter, compared to analyst estimates of $695.56 million. During the same quarter last year, the firm posted $0.45 earnings per share. The company’s quarterly revenue was up 18.9% compared to the same quarter last year. As a group, equities analysts predict that Ryan Specialty Holdings, Inc. will post 1.81 earnings per share for the current fiscal year.
Ryan Specialty Dividend Announcement
Hedge Funds Weigh In On Ryan Specialty
Institutional investors have recently modified their holdings of the company. Nebula Research & Development LLC bought a new position in shares of Ryan Specialty in the fourth quarter valued at approximately $1,284,000. Capstone Investment Advisors LLC bought a new position in Ryan Specialty during the first quarter worth $727,000. Embree Financial Group bought a new position in Ryan Specialty during the first quarter worth $1,701,000. Securian Asset Management Inc. bought a new position in Ryan Specialty during the second quarter worth $474,000. Finally, Geneva Capital Management LLC increased its position in Ryan Specialty by 12.0% during the first quarter. Geneva Capital Management LLC now owns 475,552 shares of the company’s stock worth $26,393,000 after acquiring an additional 50,947 shares during the period. Institutional investors own 84.82% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts recently commented on the stock. Wells Fargo & Company raised their price target on shares of Ryan Specialty from $60.00 to $63.00 and gave the stock an “equal weight” rating in a report on Friday, August 2nd. Wolfe Research cut shares of Ryan Specialty from an “outperform” rating to a “peer perform” rating in a report on Monday, May 6th. JPMorgan Chase & Co. lifted their target price on shares of Ryan Specialty from $54.00 to $56.00 and gave the company an “underweight” rating in a research note on Friday, August 2nd. UBS Group lifted their target price on shares of Ryan Specialty from $67.00 to $76.00 and gave the company a “buy” rating in a research note on Tuesday, August 13th. Finally, Keefe, Bruyette & Woods reiterated an “outperform” rating and issued a $62.00 target price on shares of Ryan Specialty in a research note on Tuesday, July 2nd. One research analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $62.00.
Read Our Latest Stock Report on Ryan Specialty
Ryan Specialty Company Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Further Reading
- Five stocks we like better than Ryan Specialty
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- What is the S&P 500 and How It is Distinct from Other Indexes
- MarketBeat Week in Review – 8/12 – 8/16
- Investing in Commodities: What Are They? How to Invest in Them
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.